-
September 1, 2003PREVIEW
While medical science has generated much information about the nature and causes of hepatotoxicity secondary to medications or herbal agents, clinicians have few viable options when it comes to...
-
July 1, 2003PREVIEW
A newly defined disorder, frequent heartburn, is the FDA-approved indication for nonprescription omeprazole magnesium (Prilosec OTC—Procter & Gamble). As part of this approval, FDA has...
-
April 1, 2003PREVIEW
Administration of single induction doses of infliximab (Remicade—Centocor) at times when patients with Crohn’s disease are not on immunosuppressive agents can lead to development of...
-
February 1, 2003PREVIEW
The central role played by pharmacists in the recognition and management of gastroesophageal reflux disease (GERD) is emphasized in a report recently published by the American...
-
October 1, 2002PREVIEW
The approval of adefovir dipivoxil (Hepsera—Gilead) offers patients with chronic hepatitis B a much-needed therapeutic option.
Pages
